Skip to content

Effect of Simvostatin in traumatic brain injury

Effect of Simvostatin in moderate traumatic brain injury

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201109197597N1
Enrollment
66
Registered
2011-10-15
Start date
2011-01-23
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic diffuse brain injury. Unspecified injury of head

Interventions

Intervention 1: Treatment with Simvastatin 80 mg daily for 10 days with screen Alkp weekly for drug side effect , accumulation of patients information include: GCS at admission and days 3 ,10 and CT s
Treatment - Drugs
Placebo
Treatment with Simvastatin 80 mg daily for 10 days with screen Alkp weekly for drug side effect , accumulation of patients information include: GCS at admission and days 3 ,10 and CT scan finding incl
For Placebo use a neuter substance like Simvastatin prepare by pharmacy ward administered for 10 days , accumulation of patients information include: GCS at admission and days 3 ,10 and CT scan find

Sponsors

Vice chancellor for research, Ahvaz Jundishapour University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Inclusion: patients with GCS 8-12 Exclusion: patients with GCS less 8 and more 12

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Glascow coma scale (GCS). Timepoint: Day 1,3,10. Method of measurement: According to GCS score table.;Glascow outcome scale (GOS). Timepoint: Mount 1,3,6. Method of measurement: According to GOS score table.

Secondary

MeasureTime frame
Myositis. Timepoint: Every week? alcalin phosphatase. Method of measurement: IU/L.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarhad Rahbarian

Ahvaz Jundishapour University of Medical Sciences

rahbarian.f@ajums.ac.irdr.rahbarian@gmail.com+98 61 1374 3032

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026